Literature DB >> 573770

Effects of salmon calcitonin on blood glucose and insulin levels under basal conditions and after intravenous glucose load.

A Petralito, M Lunetta, A Liuzzo, C E Fiore, G Heynen.   

Abstract

A study of the effects of salmon calcitonin (sCT) infusion on blood sugar and serum insulin levels under basal conditions and after intravenous glucose load in normal subjects is reported. Under basal conditions, a 30 min infusion of sCT at approximately a rate of 1 U/min produced a highly significant increase in the blood sugar (p less than 0.01) and a highly significant decrease in the serum insulin levels (p less than 0.01). After intravenous glucose load, there was a decrease of the coefficient of glucose utilization and of the insulin response both of which were highly significant (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 573770     DOI: 10.1007/BF03349315

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  9 in total

1.  Perifusion of isolated rat islets in vitro. Participation of the microtubular system in the biphasic release of insulin.

Authors:  P E Lacy; M M Walker; C J Fink
Journal:  Diabetes       Date:  1972-10       Impact factor: 9.461

Review 2.  Insulin biosynthesis and secretion--a still unsettled topic.

Authors:  A E Renold
Journal:  N Engl J Med       Date:  1970-01-22       Impact factor: 91.245

3.  The stimulus-secretion coupling of glucose-induced insulin release. V. The participation of a microtubular-microfilamentous system.

Authors:  W J Malaisse; F Malaisse-Lagae; M O Walker; P E Lacy
Journal:  Diabetes       Date:  1971-05       Impact factor: 9.461

Review 4.  Beta cell secretion--from the standpoint of a pathobiologist.

Authors:  P E Lacy
Journal:  Diabetes       Date:  1970-12       Impact factor: 9.461

5.  Requirement for calcium ion in insulin secretion by the perfused rat pancreas.

Authors:  D L Curry; L L Bennett; G M Grodsky
Journal:  Am J Physiol       Date:  1968-01

6.  A study of the stability of calcitonin biological activity.

Authors:  F E Newsome; R K O'Dor; C O Parkes; D H Copp
Journal:  Endocrinology       Date:  1973-04       Impact factor: 4.736

7.  Isolation and chemical properties of two calcitonins from salmon ultimobranchial glands.

Authors:  H T Keutmann; J A Parsons; J T Potts; R J Schlueter
Journal:  J Biol Chem       Date:  1970-03-25       Impact factor: 5.157

8.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

9.  [Influence of calcitonin on insulin secretion after intravenous administration of glucose].

Authors:  M Passeri; C Carapezzi; S Ceccato; D Cucinotta; E Palummeri
Journal:  G Clin Med       Date:  1974-05
  9 in total
  7 in total

1.  Synthetic salmon calcitonin is not diabetogenic in patients with normal or impaired glucose metabolism.

Authors:  G Giustina; B Cerudelli; A Cimino; C Rigosa; A Rotondi; E Radaeli
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

2.  Effect of human calcitonin (hCT) on glucose- and arginine-stimulated insulin secretion.

Authors:  S Sgambato; N Passariello; G Paolisso; A Marano; R Buoninconti; P Tesauro
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

3.  Calcitonin and insulin secretion in normal man: study with somatostatin and calcium.

Authors:  F Caviezel; R Mangili
Journal:  Acta Diabetol Lat       Date:  1983 Jan-Mar

Review 4.  Pharmacology and therapeutic use of calcitonin.

Authors:  J C Stevenson; I M Evans
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

5.  Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.

Authors:  A Starke; E Keck; M Berger; H Zimmermann
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

6.  Effects of synthetic salmon calcitonin administration on gastrin, immunoreactive insulin and growth hormone release after protein meal in uremic patients.

Authors:  M Lunetta; E Infantone; D Spanti; L Mughini
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

Review 7.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.